A framework of digital biomarkers for neurodegenerative diseases - PubMed
2 hours ago
- #health monitoring
- #digital biomarkers
- #neurodegenerative diseases
- Digital biomarkers (DBMs) are health indicators derived from digital technologies like smartphones, wearables, and sensors for continuous monitoring.
- DBMs provide richer, dynamic data than traditional point-in-time measurements, aiding in remote patient assessment and personalized care.
- They complement traditional biomarkers by screening for invasive tests and offering contextual data between clinical visits.
- This review standardizes DBM classification for neurodegenerative diseases, focusing on what, how, and why they are measured.
- DBMs have potential to transform clinical monitoring, early detection, and therapeutic interventions in neurodegenerative disorders.